Home / Netherlands / Pharming Group N.V.
Pharming Group N.V.
Short position disclosed on October 22, 2026.
Evolution of the disclosed total
January 23, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Two Sigma Investments, LP | 1.49% | new | October 22, 2026 | |
| Citadel Advisors LLC | 1.34% | +0.11 pt | October 22, 2026 | |
| D. E. Shaw & Co., L.P. | 1.03% | new | October 22, 2026 | |
| Citadel Securities (Europe) Limited | 0.80% | new | October 22, 2026 | |
| Capstone Volatility Master (Cayman) Limited | 0.72% | -0.23 pt | September 11, 2026 | |
| Walleye Capital LLC | 0.69% | new | October 22, 2026 | |
| Whitebox Advisors LLC | 0.58% | -0.02 pt | June 3, 2026 | |
| Spark Investment Management LLC | 0.52% | new | June 19, 2026 | |
| Jupiter Asset Management Ltd. | 0.51% | new | September 11, 2026 | |
| AQR Capital Management, LLC | 0.50% | new | October 8, 2026 |
In the United States PHGUF (OTC): 10,796,948 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Pharming Group N.V. Titelia
Get the moves on Pharming Group N.V. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 13, 2018 | PDT Partners, LLC | 0.81% | |
| June 8, 2018 | PDT Partners, LLC | 0.99% | |
| June 6, 2018 | PDT Partners, LLC | 1.02% | |
| June 5, 2018 | PDT Partners, LLC | 0.99% | |
| May 31, 2018 | PDT Partners, LLC | 1.06% | |
| May 23, 2018 | Oxford Asset Management | 0.53% | |
| May 22, 2018 | PDT Partners, LLC | 1.16% | |
| May 21, 2018 | PDT Partners, LLC | 1.09% | |
| May 18, 2018 | PDT Partners, LLC | 1.13% | |
| May 17, 2018 | PDT Partners, LLC | 1.27% | |
| May 17, 2018 | Marshall Wace LLP | 0.49% | |
| May 16, 2018 | PDT Partners, LLC | 1.16% | |
| May 16, 2018 | Marshall Wace LLP | 0.63% | |
| May 14, 2018 | PDT Partners, LLC | 1.25% | |
| May 14, 2018 | Marshall Wace LLP | 0.84% | |
| May 10, 2018 | PDT Partners, LLC | 1.36% | |
| May 9, 2018 | Marshall Wace LLP | 1.09% | |
| May 8, 2018 | Marshall Wace LLP | 1.27% | |
| May 7, 2018 | Marshall Wace LLP | 1.39% | |
| May 2, 2018 | Marshall Wace LLP | 1.45% | |
| April 30, 2018 | PDT Partners, LLC | 1.45% | |
| April 27, 2018 | Marshall Wace LLP | 1.58% | |
| April 27, 2018 | PDT Partners, LLC | 1.39% | |
| April 24, 2018 | PDT Partners, LLC | 1.23% | |
| April 18, 2018 | Marshall Wace LLP | 1.69% | |
| April 18, 2018 | PDT Partners, LLC | 1.11% | |
| April 17, 2018 | Marshall Wace LLP | 1.71% | |
| April 16, 2018 | PDT Partners, LLC | 1.04% | |
| April 10, 2018 | PDT Partners, LLC | 0.91% | |
| April 6, 2018 | Marshall Wace LLP | 1.65% | |
| April 5, 2018 | Marshall Wace LLP | 1.74% | |
| April 5, 2018 | PDT Partners, LLC | 0.83% | |
| April 4, 2018 | Marshall Wace LLP | 1.87% | |
| March 20, 2018 | Marshall Wace LLP | 1.99% | |
| March 19, 2018 | Marshall Wace LLP | 2.04% | |
| March 15, 2018 | Marshall Wace LLP | 2.17% | |
| March 9, 2018 | PDT Partners, LLC | 0.75% | |
| March 5, 2018 | Marshall Wace LLP | 2.25% | |
| March 1, 2018 | Marshall Wace LLP | 2.15% | |
| February 27, 2018 | Marshall Wace LLP | 2.03% | |
| February 23, 2018 | Marshall Wace LLP | 1.99% | |
| February 20, 2018 | GSA Capital Partners LLP | 0.49% | |
| February 19, 2018 | Marshall Wace LLP | 2.05% | |
| February 16, 2018 | GSA Capital Partners LLP | 0.51% | |
| February 14, 2018 | Marshall Wace LLP | 1.95% | |
| February 14, 2018 | PDT Partners, LLC | 0.61% | |
| February 9, 2018 | Marshall Wace LLP | 1.60% | |
| February 8, 2018 | Marshall Wace LLP | 1.23% | |
| February 7, 2018 | Marshall Wace LLP | 1.38% | |
| February 6, 2018 | Marshall Wace LLP | 1.47% |
Download 1,161 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 12.31% of the capital sold short
- Signify N.V. 8.64% of the capital sold short
- Fugro N.V. 4.25% of the capital sold short
- Imcd N.V. 3.46% of the capital sold short
- DSM-Firmenich AG 3.28% of the capital sold short
- Basic-Fit N.V. 2.74% of the capital sold short
- NSI N.V. 2.47% of the capital sold short
- Sligro Food Group N.V. 2.31% of the capital sold short
- TomTom N.V. 2.25% of the capital sold short
- PostNL N.V. 2.22% of the capital sold short
- Alfen N.V. 2.02% of the capital sold short
- Arcadis N.V. 1.60% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Pharming Group N.V., source AFM, data as at October 22, 2026, https://www.quivad.com/action/pharming-group-n-v?page=23